ENGN
enGene Therapeutics Inc.
Company overview
- Market capitalization
- $132.02M
- Employees
- 81
- Latest publication
- 2026-09-29
About enGene Therapeutics Inc.
enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.
Financial statements
Income Quarterly
| Metric | Q3 20262026-07-31 · USD | Q1 20262026-01-31 · USD | Q4 20252025-10-31 · USD | Q3 20252025-07-31 · USD | Q2 20252025-04-30 · USD | Q1 20252025-01-31 · USD | Q4 20242024-10-31 · USD | Q3 20242024-07-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 20,090,000USD | 22,255,000USD | 31,722,000USD | 22,575,000USD | 20,209,000USD | 19,974,000USD | 11,273,000USD | 11,549,000USD |
| Total Operating Expenses | 34,014,000USD | 30,996,000USD | 39,481,000USD | 29,947,000USD | 27,124,000USD | 26,613,000USD | 17,455,000USD | 16,759,000USD |
| Net Income | 32,501,000USD | -29,752,000USD | -37,880,000USD | -28,991,000USD | -25,815,000USD | -24,616,000USD | -15,299,000USD | -14,148,000USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 0USD | 480,000USD | 0USD |
| Cost Of Revenue | — | 189,000USD | 171,000USD | 130,000USD | 106,000USD | 102,000USD | — | 82,000USD |
| Gross Profit | — | -189,000USD | -171,000USD | -130,000USD | -106,000USD | -102,000USD | 240,000USD | -82,000USD |
| Selling General Administrative | — | 8,930,000USD | 10,024,000USD | 6,679,000USD | 5,979,000USD | 6,639,000USD | 7,700,000USD | 4,682,000USD |
| Operating Income | — | -31,185,000USD | -39,481,000USD | -29,947,000USD | -27,124,000USD | -26,613,000USD | -17,455,000USD | -16,759,000USD |
| Interest Income | — | 2,740,000USD | 1,975,000USD | 2,233,000USD | 2,488,000USD | 2,730,000USD | 3,024,000USD | 3,380,000USD |
| Interest Expense | — | 732,000USD | 750,000USD | 758,000USD | 734,000USD | 752,000USD | 756,000USD | 751,000USD |
| Net Interest Income | — | 2,008,000USD | 1,225,000USD | 1,475,000USD | 1,754,000USD | 1,978,000USD | 2,268,000USD | 2,629,000USD |
| Income Before Tax | — | -29,752,000USD | -38,377,000USD | -28,752,000USD | -25,575,000USD | -24,598,000USD | -15,280,000USD | -14,177,000USD |
| Tax Provision | — | 0USD | -497,000USD | 239,000USD | 240,000USD | 18,000USD | 19,000USD | -29,000USD |
| Net Income From Continuing Ops | — | -29,752,000USD | -37,880,000USD | -28,991,000USD | -25,815,000USD | -24,616,000USD | -15,299,000USD | -14,148,000USD |
| Ebit | — | -29,020,000USD | -37,627,000USD | -27,994,000USD | -24,841,000USD | -23,846,000USD | -14,524,000USD | -13,426,000USD |
| Ebitda | — | -28,831,000USD | -37,456,000USD | -27,864,000USD | -24,735,000USD | -23,744,000USD | -14,441,000USD | -13,344,000USD |
| Depreciation And Amortization | — | 189,000USD | 171,000USD | 130,000USD | 106,000USD | 102,000USD | 83,000USD | 82,000USD |
| Reconciled Depreciation | — | 189,000USD | 171,000USD | 130,000USD | 106,000USD | 102,000USD | 83,000USD | 82,000USD |
| Total Other Income Expense Net | — | 1,433,000USD | 1,104,000USD | 1,195,000USD | 1,549,000USD | 2,015,000USD | 2,175,000USD | 2,582,000USD |
| Unclassified Operating Expenses | — | — | -2,265,000USD | — | — | — | -1,518,000USD | — |
| Income Tax Expense | — | — | -497,000USD | 239,000USD | 240,000USD | 18,000USD | 19,000USD | -29,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 636,000USD | — | 528,000USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-10-31 · USD | FY 20242024-10-31 · USD | FY 20232023-10-31 · USD | FY 20222022-10-31 · USD | FY 20212021-10-31 · USD | FY 20202020-10-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 509,000USD | 323,000USD | 175,000USD | — | — | — |
| Gross Profit | -509,000USD | -323,000USD | -175,000USD | — | — | — |
| Research Development | 94,480,000USD | 38,315,000USD | 16,458,000USD | 15,467,000USD | 12,462,000USD | 10,614,000USD |
| Selling General Administrative | 28,685,000USD | 23,982,000USD | 8,470,000USD | 3,260,000USD | 3,155,000USD | 3,239,000USD |
| Total Operating Expenses | 123,165,000USD | 62,297,000USD | 26,060,000USD | 19,427,000USD | 15,870,000USD | 13,853,000USD |
| Operating Income | -123,165,000USD | -62,297,000USD | -26,060,000USD | -19,427,000USD | -15,870,000USD | -13,853,000USD |
| Interest Income | 9,426,000USD | 10,413,000USD | 1,117,000USD | 129,000USD | 25,000USD | 56,000USD |
| Interest Expense | 2,994,000USD | 2,798,000USD | 4,953,000USD | 1,423,000USD | 5,024,000USD | 3,699,000USD |
| Net Interest Income | 6,432,000USD | 7,615,000USD | -3,836,000USD | -1,294,000USD | -4,999,000USD | -3,643,000USD |
| Income Before Tax | -117,302,000USD | -55,161,000USD | -99,900,000USD | -24,440,000USD | -23,441,000USD | -15,068,000USD |
| Tax Provision | 0USD | -19,000USD | 17,000USD | 22,000USD | 0USD | 0USD |
| Net Income | -117,302,000USD | -55,142,000USD | -99,917,000USD | -24,462,000USD | -23,441,000USD | -15,068,000USD |
| Net Income From Continuing Ops | -117,302,000USD | -55,142,000USD | -99,917,000USD | -24,462,000USD | -23,441,000USD | -15,068,000USD |
| Ebit | -114,308,000USD | -52,363,000USD | -94,947,000USD | -23,017,000USD | -18,417,000USD | -13,161,000USD |
| Ebitda | -113,799,000USD | -52,040,000USD | -94,772,000USD | -22,779,000USD | -18,145,000USD | -12,902,000USD |
| Depreciation And Amortization | 509,000USD | 323,000USD | 175,000USD | 238,000USD | 272,000USD | 259,000USD |
| Reconciled Depreciation | 509,000USD | 323,000USD | 175,000USD | 238,000USD | 272,000USD | 259,000USD |
| Total Other Income Expense Net | 5,863,000USD | 7,136,000USD | -73,840,000USD | -5,013,000USD | -7,571,000USD | 2,428,000USD |
| Income Tax Expense | — | -19,000USD | 17,000USD | 22,000USD | 4,896,000USD | 4,335,000USD |
| Unclassified Operating Expenses | — | — | 1,132,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-07-31 · USD | Q1 20262026-01-31 · USD | Q4 20252025-10-31 · USD | Q3 20252025-07-31 · USD | Q2 20252025-04-30 · USD | Q1 20252025-01-31 · USD | Q4 20242024-10-31 · USD | Q3 20242024-07-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 288,322,000USD | 337,113,000USD | 221,468,000USD | 245,550,000USD | 266,651,000USD | 285,932,000USD | 311,173,000USD | 266,879,000USD |
| Cash And Equivalents | 41,025,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 266,320,000USD | 275,948,000USD | 193,815,000USD | 201,985,000USD | 217,464,000USD | 213,888,000USD | 238,404,000USD | 257,753,000USD |
| Short Term Investments | 225,295,000USD | 239,335,000USD | 143,663,000USD | 169,362,000USD | 159,919,000USD | 151,542,000USD | 65,400,000USD | 75,000USD |
| Long Term Investments | 0USD | 36,601,000USD | 8,522,000USD | 23,011,000USD | 34,109,000USD | 58,979,000USD | 59,527,000USD | — |
| Total Current Assets | 277,900,000USD | 289,216,000USD | 201,391,000USD | 211,312,000USD | 227,974,000USD | 222,320,000USD | 247,362,000USD | 262,694,000USD |
| Other Current Assets | 10,526,000USD | 12,071,000USD | 5,349,000USD | 8,618,000USD | 9,977,000USD | 8,002,000USD | 7,926,000USD | 4,700,000USD |
| Other Non Current Assets | 1,389,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 58,032,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 27,209,000USD | 24,609,000USD | 31,979,000USD | 20,440,000USD | 18,001,000USD | 12,955,000USD | 14,661,000USD | 13,458,000USD |
| Total Stockholder Equity | 230,290,000USD | 281,546,000USD | 167,710,000USD | 200,672,000USD | 227,291,000USD | 249,950,000USD | 272,612,000USD | 230,329,000USD |
| Total Equity Including Noncontrolling Interest | 230,290,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 9,033,000USD | 9,911,000USD | 10,193,000USD | 9,848,000USD | 3,193,000USD | 3,057,000USD | 2,910,000USD | 2,804,000USD |
| Accounts Payable | 2,541,000USD | 2,435,000USD | 6,688,000USD | 2,384,000USD | 1,567,000USD | 2,605,000USD | 1,411,000USD | 2,862,000USD |
| Short Term Debt | 2,249,000USD | 2,506,000USD | 10,016,000USD | 6,939,000USD | 4,001,000USD | 2,106,000USD | 1,122,000USD | 1,763,000USD |
| Common Stock | 632,021,000USD | 631,992,000USD | 513,280,999USD | 510,164,000USD | 510,121,000USD | 509,812,000USD | 509,811,000USD | 453,479,000USD |
| Retained Earnings | -464,512,000USD | -401,784,000USD | -372,032,000USD | -334,152,000USD | -305,161,000USD | -279,346,000USD | -254,730,000USD | -239,431,000USD |
| Accumulated Other Comprehensive Income | -1,351,000USD | -842,000USD | -888,000USD | -1,209,000USD | -969,000USD | -1,275,000USD | -1,419,000USD | -1,016,000USD |
| Total Liab | — | 55,567,000USD | 53,758,000USD | 44,878,000USD | 39,360,000USD | 35,982,000USD | 38,561,000USD | 36,550,000USD |
| Other Current Liab | — | 19,668,000USD | 15,275,000USD | 11,117,000USD | 12,105,000USD | 8,155,999USD | 12,128,000USD | 8,833,000USD |
| Capital Stock | — | 631,992,000USD | 513,281,000USD | 510,164,000USD | 510,121,000USD | 509,812,000USD | 509,811,000USD | 453,479,000USD |
| Cash | — | 36,613,000USD | 50,152,000USD | 32,622,999USD | 57,545,000USD | 62,346,000USD | 173,004,000USD | 257,678,000USD |
| Net Debt | — | -3,149,000USD | -18,357,000USD | -1,245,999USD | -32,185,000USD | -37,213,000USD | -147,982,000USD | -232,823,000USD |
| Short Long Term Debt | — | 188,000USD | 8,002,000USD | 5,412,000USD | 3,570,000USD | 1,690,000USD | 699,000USD | 1,341,000USD |
| Short Long Term Debt Total | — | 33,464,000USD | 31,795,000USD | 31,377,000USD | 25,360,000USD | 25,133,000USD | 25,022,000USD | 24,855,000USD |
| Long Term Debt | — | 24,736,000USD | 15,324,000USD | 17,706,000USD | 20,023,000USD | 21,696,000USD | 22,473,000USD | 21,612,000USD |
| Net Receivables | — | 1,197,000USD | 2,227,000USD | 709,000USD | 533,000USD | 430,000USD | 1,032,000USD | 241,000USD |
| Property Plant Equipment Gross | — | 12,203,000USD | 12,296,000USD | 11,780,000USD | 5,011,000USD | 4,769,000USD | 4,520,000USD | 4,331,000USD |
| Common Stock Shares Outstanding | — | 67,263,234shares | 51,304,680shares | 51,097,711shares | 51,019,000shares | 50,977,000shares | 45,107,000shares | 44,169,000shares |
| Non Current Assets Total | — | 47,897,000USD | 20,077,000USD | 34,238,000USD | 38,677,000USD | 63,612,000USD | 63,811,000USD | 4,185,000USD |
| Non Current Liabilities Total | — | 30,958,000USD | 21,779,000USD | 24,438,000USD | 21,359,000USD | 23,027,000USD | 23,900,000USD | 23,092,000USD |
| Non Currrent Assets Other | — | 1,385,000USD | 1,362,000USD | 1,379,000USD | 1,375,000USD | 1,576,000USD | 1,374,000USD | 1,381,000USD |
| Net Working Capital | — | 264,607,000USD | 169,412,000USD | 190,872,000USD | 209,973,000USD | 209,365,000USD | 232,701,000USD | 249,236,000USD |
| Unclassified Non Current Liabilities | — | 6,222,000USD | 6,455,000USD | 6,732,000USD | 1,336,000USD | 1,331,000USD | 1,427,000USD | 1,480,000USD |
| Unclassified Equity | — | -579,812,000USD | -485,931,999USD | -484,295,000USD | -486,821,000USD | -489,053,000USD | -490,861,000USD | -436,182,000USD |
| Unclassified Current Liabilities | — | — | -8,002,000USD | -5,412,000USD | -3,242,000USD | -1,601,999USD | — | -3,515,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 2,174,000USD |
| Inventory | — | — | — | — | — | — | — | 75,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-10-31 · USD | FY 20242024-10-31 · USD | FY 20232023-10-31 · USD | FY 20222022-10-31 · USD | FY 20212021-10-31 · USD | FY 20202020-10-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 221,468,000USD | 311,173,000USD | 86,959,000USD | 132,043,138USD | 131,446,350USD | — |
| Other Current Assets | 5,349,000USD | 7,926,000USD | 1,500,000USD | 197,653USD | 498,591USD | — |
| Total Liab | 53,758,000USD | 38,561,000USD | 14,473,000USD | 4,621,009USD | 4,054,947USD | — |
| Total Stockholder Equity | 167,710,000USD | 272,612,000USD | 72,486,000USD | 127,422,129USD | 127,391,403USD | — |
| Other Current Liab | 15,275,000USD | 12,128,000USD | 3,500,000USD | 871,509USD | 327,447USD | — |
| Common Stock | 513,280,999USD | 509,811,000USD | 259,373,000USD | 131,531,650USD | 129,669,725USD | — |
| Capital Stock | 513,281,000USD | 509,811,000USD | 259,373,000USD | 16,390,000USD | 16,363,000USD | — |
| Retained Earnings | -372,032,000USD | -254,730,000USD | -199,588,000USD | -4,109,521USD | -2,278,322USD | — |
| Cash | 50,152,000USD | 173,004,000USD | 81,521,000USD | 314,151USD | 1,069,298USD | — |
| Cash And Short Term Investments | 193,815,000USD | 238,404,000USD | 81,597,000USD | 314,151USD | 1,069,298USD | — |
| Total Current Assets | 201,391,000USD | 247,362,000USD | 85,440,000USD | 511,804USD | 1,567,889USD | — |
| Total Current Liabilities | 31,979,000USD | 14,661,000USD | 5,257,000USD | 893,509USD | 327,447USD | — |
| Net Debt | -18,357,000USD | -147,982,000USD | -71,743,000USD | -314,151USD | -1,069,298USD | — |
| Short Term Debt | 10,016,000USD | 1,122,000USD | 562,000USD | 1,265,000USD | 1,109,000USD | — |
| Short Long Term Debt | 8,002,000USD | 699,000USD | 562,000USD | 1,265,000USD | 1,048,000USD | — |
| Short Long Term Debt Total | 31,795,000USD | 25,022,000USD | 9,778,000USD | 32,110,000USD | 4,156,000USD | — |
| Long Term Debt | 15,324,000USD | 22,473,000USD | 9,216,000USD | 30,845,000USD | 3,047,000USD | — |
| Long Term Investments | 8,522,000USD | 59,527,000USD | 0USD | — | — | — |
| Short Term Investments | 143,663,000USD | 65,400,000USD | 76,000USD | — | — | — |
| Net Receivables | 2,227,000USD | 1,032,000USD | 2,343,000USD | 1,336,000USD | 1,622,000USD | — |
| Accounts Payable | 6,688,000USD | 1,411,000USD | 1,156,000USD | 723,000USD | 1,001,000USD | — |
| Property Plant Equipment Net | 10,193,000USD | 2,910,000USD | 589,000USD | 387,000USD | 571,000USD | — |
| Property Plant Equipment Gross | 12,296,000USD | 4,520,000USD | 2,316,000USD | 1,940,000USD | 2,034,000USD | — |
| Accumulated Other Comprehensive Income | -888,000USD | -1,419,000USD | -1,016,000USD | -1,016,000USD | -2,183,000USD | — |
| Common Stock Shares Outstanding | 51,119,479shares | 44,638,000shares | 23,557,000shares | 15,813,000shares | 15,813,000shares | 15,813,000shares |
| Non Current Assets Total | 20,077,000USD | 63,811,000USD | 1,519,000USD | 131,531,333USD | 129,878,460USD | — |
| Non Current Liabilities Total | 21,779,000USD | 23,900,000USD | 9,216,000USD | 3,727,500USD | 3,727,500USD | — |
| Non Currrent Assets Other | 1,362,000USD | 1,374,000USD | 860,000USD | -130,592,333USD | 209,051USD | — |
| Net Working Capital | 169,412,000USD | 232,701,000USD | 80,183,000USD | 17,479,000USD | 10,301,000USD | — |
| Unclassified Current Liabilities | -8,002,000USD | — | -3,843,000USD | -3,231,000USD | -4,243,000USD | — |
| Unclassified Non Current Liabilities | 6,455,000USD | 1,427,000USD | — | -27,117,500USD | — | — |
| Unclassified Equity | -485,931,999USD | -490,861,000USD | -245,656,000USD | -15,374,000USD | -14,180,000USD | — |
| Current Deferred Revenue | — | — | 3,320,000USD | — | 1,085,000USD | — |
| Inventory | — | — | 76,000USD | 74,000USD | 81,000USD | — |
| Unclassified Current Assets | — | — | — | -1,410,000USD | -1,703,000USD | — |
| Unclassified Non Current Assets | — | — | — | 131,144,333USD | 129,098,409USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q3 20262026-07-31 · USD |
|---|---|
| Depreciation | 500,000USD |
| Stock Based Compensation | 14,758,000USD |
| Other Non Cash Items | -488,000USD |
| Change To Liabilities | 2,792,000USD |
| Change In Working Capital | -8,059,000USD |
| Operating Cash Flow | -78,347,000USD |
| Capital Expenditures | -251,000USD |
| Net Investments | -72,287,000USD |
| Investing Cash Flow | -72,538,000USD |
| Net Debt Issuance | 25,000,000USD |
| Unclassified Financing Cash Flow | 116,757,000USD |
| Financing Cash Flow | 141,757,000USD |
| Effect Of Forex Changes On Cash | 1,000USD |
| Change In Cash | -9,127,000USD |
| End Cash Flow | 41,025,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-01-31 · USD | Q4 20252025-10-31 · USD | Q3 20252025-07-31 · USD | Q2 20252025-04-30 · USD | Q1 20252025-01-31 · USD | Q4 20242024-10-31 · USD | Q3 20242024-07-31 · USD | Q2 20242024-04-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -29,752,000USD | -37,880,000USD | -28,991,000USD | -25,815,000USD | -24,616,000USD | -15,299,000USD | -14,148,000USD | -14,984,000USD |
| Depreciation | 189,000USD | 171,000USD | 130,000USD | 106,000USD | 102,000USD | 83,000USD | 82,000USD | 78,000USD |
| Stock Based Compensation | 2,803,000USD | 2,606,000USD | 2,581,000USD | 2,650,000USD | 1,809,000USD | 1,656,000USD | 1,460,000USD | 1,917,000USD |
| Other Non Cash Items | 395,000USD | 15,000USD | -420,000USD | -1,037,000USD | -390,000USD | 25,000USD | 281,000USD | 190,000USD |
| Change To Account Receivables | -271,000USD | -217,000USD | -178,000USD | -102,000USD | -98,000USD | -90,000USD | 971,000USD | -83,000USD |
| Change In Working Capital | -2,538,000USD | 10,126,000USD | 1,066,000USD | 1,149,000USD | -2,601,000USD | -6,033,000USD | 5,144,000USD | -1,363,000USD |
| Total Cash From Operating Activities | -28,903,000USD | -24,962,000USD | -25,634,000USD | -22,947,000USD | -25,696,000USD | -19,568,000USD | -7,181,000USD | -14,162,000USD |
| Capital Expenditures | -153,000USD | -437,000USD | -704,000USD | -45,000USD | -299,000USD | -238,000USD | -2,000USD | -179,000USD |
| Free Cash Flow | -29,056,000USD | -25,399,000USD | -26,338,000USD | -22,992,000USD | -25,995,000USD | -19,806,000USD | -7,183,000USD | -14,341,000USD |
| Investments | -126,144,000USD | 40,937,000USD | 1,379,000USD | 17,947,000USD | -84,964,000USD | -125,266,000USD | -2,000USD | -179,000USD |
| Total Cashflows From Investing Activities | -126,297,000USD | 40,500,000USD | 1,379,000USD | 17,947,000USD | -84,964,000USD | -125,266,000USD | -2,000USD | -179,000USD |
| Net Borrowings | 1,947,000USD | 0USD | -699,000USD | 0USD | 0USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | 141,660,000USD | 1,991,000USD | -667,000USD | 199,000USD | 1,000USD | 60,160,000USD | 51,000USD | 193,505,000USD |
| Issuance Of Capital Stock | 126,250,000USD | 0USD | 0USD | 0USD | 0USD | 60,149,000USD | 0USD | — |
| Change In Cash | -13,539,000USD | 17,529,000USD | -24,922,000USD | -4,801,000USD | -110,658,000USD | -84,674,000USD | -7,132,000USD | 179,164,000USD |
| Begin Period Cash Flow | 50,152,000USD | 32,622,999USD | 57,545,000USD | 62,346,000USD | 173,004,000USD | 257,678,000USD | 264,810,000USD | 85,646,000USD |
| End Period Cash Flow | 36,613,000USD | 50,152,000USD | 32,623,000USD | 57,545,000USD | 62,346,000USD | 173,004,000USD | 257,678,000USD | 264,810,000USD |
| Other Cashflows From Financing Activities | 141,660,000USD | — | -667,000USD | 199,000USD | 1,000USD | 13,066,000USD | -187,614,000USD | 193,505,000USD |
| Unclassified Financing Cash Flow | -128,197,000USD | 1,991,000USD | — | — | — | -13,055,000USD | 187,665,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | -125,028,000USD | -125,028,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | 125,327,000USD | 125,266,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-10-31 · USD | FY 20242024-10-31 · USD | FY 20232023-10-31 · USD | FY 20222022-10-31 · USD | FY 20212021-10-31 · USD | FY 20202020-10-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -117,302,000USD | -55,142,000USD | -99,917,000USD | -24,462,000USD | -23,441,000USD | -15,068,000USD |
| Depreciation | 509,000USD | 323,000USD | 175,000USD | 238,000USD | 272,000USD | 259,000USD |
| Stock Based Compensation | 9,646,000USD | 5,324,000USD | 3,450,000USD | 116,000USD | 435,000USD | 150,000USD |
| Other Non Cash Items | -1,832,000USD | 1,119,000USD | 72,066,000USD | 4,342,000USD | 7,786,000USD | 1,211,000USD |
| Change To Account Receivables | -595,000USD | 2,011,000USD | -1,007,000USD | 143,000USD | 295,000USD | -149,000USD |
| Change In Working Capital | 9,740,000USD | 95,000USD | -517,000USD | 2,174,000USD | -1,036,000USD | 387,000USD |
| Total Cash From Operating Activities | -99,239,000USD | -48,281,000USD | -24,743,000USD | -17,592,000USD | -15,984,000USD | -13,061,000USD |
| Capital Expenditures | -1,485,000USD | -925,000USD | -318,000USD | -153,000USD | -248,000USD | -192,000USD |
| Free Cash Flow | -100,724,000USD | -49,206,000USD | -25,061,000USD | -17,745,000USD | -16,232,000USD | -13,253,000USD |
| Investments | -23,653,000USD | -125,953,000USD | -318,000USD | -153,000USD | -247,000USD | -192,000USD |
| Total Cashflows From Investing Activities | -25,138,000USD | -125,953,000USD | -318,000USD | -153,000USD | -247,000USD | -192,000USD |
| Net Borrowings | -699,000USD | 13,055,000USD | 33,269,000USD | 28,390,000USD | 7,068,000USD | — |
| Total Cash From Financing Activities | 1,524,000USD | 265,716,000USD | 86,147,000USD | 27,967,000USD | 22,525,000USD | 12,848,000USD |
| Issuance Of Capital Stock | 0USD | 260,149,000USD | 56,892,000USD | 12,000USD | 15,601,000USD | 0USD |
| Change In Cash | -122,852,000USD | 91,483,000USD | 61,087,000USD | 9,417,000USD | 6,392,000USD | -456,000USD |
| Begin Period Cash Flow | 173,004,000USD | 81,521,000USD | 20,434,000USD | 11,017,000USD | 4,625,000USD | 5,081,000USD |
| End Period Cash Flow | 50,152,000USD | 173,004,000USD | 81,521,000USD | 20,434,000USD | 11,017,000USD | 4,625,000USD |
| Unclassified Financing Cash Flow | 2,223,000USD | — | — | — | -15,587,000USD | 13,010,000USD |
| Other Cashflows From Financing Activities | — | -7,488,000USD | -4,014,000USD | -423,000USD | 15,443,000USD | -162,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | 1,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.